EA
ABBV icon

Ellsworth Advisors’s AbbVie ABBV Stock Holding History

Ellsworth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-941
Closed -$205K – 183
2026
Q1 		$205K Buy
+941
New +$209K 0.04% 161

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Ellsworth Advisors's ABBV Position: Q2 2026 in Review

Ellsworth Advisors sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 941 shares — an estimated $205K sold.

Ellsworth Advisors first reported a position in ABBV in Q1 2026 and held it in 1 quarter. The position peaked at $205K in Q1 2026. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ellsworth Advisors reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Ellsworth Advisors sold 941 AbbVie shares in Q2 2026, an estimated $205K.
  • Ellsworth Advisors first reported a position in AbbVie in Q1 2026 and held it in 1 quarter.
  • Ellsworth Advisors's AbbVie position peaked at $205K in Q1 2026.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ellsworth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.